Entrar Registro gratuito

Last updated: 1 July 2024 at 4:12pm EST

Timothy Wright Net Worth




The estimated Net Worth of Timothy Wright is at least $846 mil dollars as of 16 June 2021. Mr. Wright owns over 16,853 units of Agenus Inc stock worth over $284,205 and over the last 17 years he sold AGEN stock worth over $0. In addition, he makes $562,141 as Lead Independent Director at Agenus Inc.

Mr. Wright AGEN stock SEC Form 4 insiders trading

Timothy has made over 2 trades of the Agenus Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 16,853 units of AGEN stock worth $95,051 on 16 June 2021.

The largest trade he's ever made was exercising 20,338 units of Agenus Inc stock on 19 June 2020 worth over $114,706. On average, Timothy trades about 454 units every 4 days since 2007. As of 16 June 2021 he still owns at least 50,391 units of Agenus Inc stock.

You can see the complete history of Mr. Wright stock trades at the bottom of the page.





Timothy Wright biography

Timothy R. Wright serves as Lead Independent Director of the Company. Mr. Wright is the Chief Executive Officer of MiMedX Group, Inc. (“MiMedX”), a position that he has held since May 2019. MiMedX is an advanced wound care and emerging therapeutic biologics company. Mr. Wright has also been a Director of MiMedX since June 2019. Mr. Wright also serves as a Partner at Signal Hill Advisors, LLC, a position he has held since February 2011. Mr. Wright also serves as chairman of The Ohio State University Comprehensive Cancer Center Drug Development Institute, and director of the Ohio State University Innovation Foundation. Mr. Wright was the President and Chief Executive Officer and a director of M2Gen Corp., a privately held health informatics company, between July 2017 and September 2018. From April 2015 through July 2017, Mr. Wright was the Executive Vice President, Mergers and Acquisitions, Strategy and Innovation at Teva Pharmaceuticals Industries Ltd. From September 2013 to March 2015, Mr. Wright served as head of The Ohio State University Technology Transfer Office. From July 2011 to July 2012, Mr. Wright served as Chairman, Interim CEO, and a member of the Board of Directors of Curaxis Pharmaceuticals Corporation, a research based company dedicated to finding cures for age-related diseases, including Alzheimer’s disease and cancer. Prior to Mr. Wright’s tenure at Curaxis, the company had been experiencing financial difficulties and, as a result, Curaxis filed for Chapter 11 bankruptcy in July 2012. Prior to that, Mr. Wright served as President of the Imaging Solutions and Pharmaceutical Products Sector of Covidien from February 2007 until December 2010. Mr. Wright brings to our Board over 30 years of global pharmaceutical industry experience in general management, product development, and commercialization as well as business restructuring and transaction experience. Mr. Wright earned his bachelor’s degree from The Ohio State University.

What is the salary of Timothy Wright?

As the Lead Independent Director of Agenus Inc, the total compensation of Timothy Wright at Agenus Inc is $562,141. There are 6 executives at Agenus Inc getting paid more, with Garo Armen having the highest compensation of $9,937,040.



How old is Timothy Wright?

Timothy Wright is 62, he's been the Lead Independent Director of Agenus Inc since 2009. There are 4 older and 8 younger executives at Agenus Inc. The oldest executive at Agenus Inc is Wadih Jordan, 85, who is the Independent Director.

What's Timothy Wright's mailing address?

Timothy's mailing address filed with the SEC is C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON, MA, 02421.

Insiders trading at Agenus Inc

Over the last 23 years, insiders at Agenus Inc have traded over $24,466,328 worth of Agenus Inc stock and bought 13,248,226 units worth $63,837,873 . The most active insiders traders include Associates Gp Llcqvt Fund V..., Noubar Afeyan, eCorp Incyte. On average, Agenus Inc executives and independent directors trade stock every 99 days with the average trade being worth of $2,230,885. The most recent stock trade was executed by Garo H Armen on 15 February 2024, trading 500,000 units of AGEN stock currently worth $325,000.



What does Agenus Inc do?

agenus is an immunology company discovering and developing novel checkpoint modulators, vaccines and adjuvants to treat cancer and other diseases. we are a dedicated group of scientists, researchers, biotechnologists, physicians, and businesspeople working together toward one goal: to discover and develop therapies that can unleash the innate power of the body’s immune system to treat and potentially cure hard-to-treat cancers and other diseases. our product candidates are designed to work by educating and activating the body’s immune system for a precise and potent attack on cancer. our strategy is to help unlock the potential of one of the most exciting breakthrough areas in cancer treatment in decades, and to develop single agent and combination immune-oncology therapies that can help save lives. our approaches are driven by three platform technologies, including: • our antibody platforms, including our proprietary retrocyte display™ and secant® technologies, and our antibody



What does Agenus Inc's logo look like?

Agenus Inc logo

Complete history of Mr. Wright stock trades at Agenus Inc

Data
#
Companhia
 Acionista maioritário
Trans.
Transação
 Ações Preço por ação Preço total Ações após Fonte
16 Jun 2021 AGEN Agenus Inc Timothy Wright
Exercício de opção 16,853 $100.00 $1,685,300
16 Jun 2021
50,391 ↗
19 Jun 2020 AGEN Agenus Inc Timothy Wright
Exercício de opção 20,338 $76.60 $1,557,891
19 Jun 2020
53,876 ↗


Agenus Inc executives and stock owners

Agenus Inc executives and other stock owners filed with the SEC include: